• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微血管侵犯型肝细胞癌手术切除及切缘的意义:一项系统评价与Meta分析

Significance of surgical resection and resection margins for hepatocellular carcinoma with microvascular invasion: a systematic review and meta-analysis.

作者信息

Shi Shuxun, Cui Xi, Liu Cuicui, Li Hanghang, Zhai Rui

机构信息

Affiliated Hospital of Gansu University of Traditional Chinese Medicine.

Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu Province, China.

出版信息

Eur J Gastroenterol Hepatol. 2025 Jul 8. doi: 10.1097/MEG.0000000000003028.

DOI:10.1097/MEG.0000000000003028
PMID:40631501
Abstract

OBJECTIVE

For hepatocellular carcinoma (HCC) with microvascular invasion (MVI), the choice of surgical resection (SR) and resection margins (RMs) remains to be determined. The aim of this study was to discuss the relationship between SR and RM and MVI-positive HCC.

METHODS

PubMed, Embase, Web of Science, and Cochrane Library were searched up to 1 September 2024. The methodological quality of eligible articles was assessed using the Newcastle-Ottawa Scale (NOS). Effect models were selected to pool the HR and 95% CI of recurrence and overall survival (OS) based on the presence of heterogeneity to assess the impact of SR and RM in MVI-positive HCC.

RESULTS

A total of 12 articles with 6747 cases were included. NOS scale indicated that the studies were of high quality. The results showed that narrow RM were a risk factor for postoperative recurrence and OS in MVI-positive HCC, with a pooled HR of 1.76 (95% CI: 1.49, 2.07) and 1.99 (95% CI: 1.58, 2.49), respectively; whereas nonanatomical resection (NAR) was another risk factor for postoperative recurrence and OS, with a pooled HR of 1.33 (95% CI: 1.15, 1.54) and 1.42 (95% CI: 1.15, 1.75), so wide RM and anatomical resection (AR) was beneficial for postoperative recurrence and long-term survival. In the subgroups, narrow RM were more than twice the risk factor for TTR compared with wide RM; and in the SR subgroup, studies from the Japanese had more than double the risk factor for postoperative recurrence and OS compared with China.

CONCLUSION

For HCC with MVI, treatment modalities recommending anatomical resection and wide margins will have beneficial effects on postoperative recurrence and long-term survival.

摘要

目的

对于伴有微血管侵犯(MVI)的肝细胞癌(HCC),手术切除(SR)方式及切缘(RM)的选择仍有待确定。本研究旨在探讨SR、RM与MVI阳性HCC之间的关系。

方法

检索截至2024年9月1日的PubMed、Embase、Web of Science和Cochrane图书馆。使用纽卡斯尔-渥太华量表(NOS)评估符合条件文章的方法学质量。根据异质性情况选择效应模型汇总复发和总生存(OS)的HR及95%CI,以评估SR和RM对MVI阳性HCC的影响。

结果

共纳入12篇文章,涉及6747例病例。NOS量表显示这些研究质量较高。结果表明,切缘窄是MVI阳性HCC术后复发和OS的危险因素,汇总HR分别为1.76(95%CI:1.49,2.07)和1.99(95%CI:1.58,2.49);而非解剖性切除(NAR)是术后复发和OS的另一个危险因素,汇总HR分别为1.33(95%CI:1.15,1.54)和1.42(95%CI:1.15,1.75),因此宽切缘和解剖性切除(AR)有利于术后复发和长期生存。在亚组分析中,与宽切缘相比,窄切缘是术后无复发生存期(TTR)危险因素的两倍以上;在SR亚组中,日本的研究与中国的研究相比,术后复发和OS的危险因素是其两倍以上。

结论

对于伴有MVI的HCC,推荐采用解剖性切除和宽切缘的治疗方式将对术后复发和长期生存产生有益影响。

相似文献

1
Significance of surgical resection and resection margins for hepatocellular carcinoma with microvascular invasion: a systematic review and meta-analysis.微血管侵犯型肝细胞癌手术切除及切缘的意义:一项系统评价与Meta分析
Eur J Gastroenterol Hepatol. 2025 Jul 8. doi: 10.1097/MEG.0000000000003028.
2
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗:系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
3
[Comparison of the efficacy of anatomical resection versus hepatic parenchymal preservation preference in patients with solitary small hepatocellular carcinoma and cirrhosis: a multicenter retrospective study].[孤立性小肝细胞癌合并肝硬化患者解剖性切除与肝实质保留优先策略疗效比较:一项多中心回顾性研究]
Zhonghua Gan Zang Bing Za Zhi. 2025 Apr 20;33(4):348-358. doi: 10.3760/cma.j.cn501113-20250315-00097.
4
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.治疗胶质母细胞瘤进展或复发的选择:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Bisphosphonates in multiple myeloma: an updated network meta-analysis.双膦酸盐类药物在多发性骨髓瘤中的应用:一项更新的网状Meta分析
Cochrane Database Syst Rev. 2017 Dec 18;12(12):CD003188. doi: 10.1002/14651858.CD003188.pub4.
8
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.